The Clinical Efficacy Observation Of Promoting Blood Circulation And Removing Stasis Drugs To The Patients Of Systemic Inflammatory Response Syndrome

Objective: to observe the clinical efficacy of promoting blood circulation andremoving stasis drugs to the patients of SIRS.Methods: according to the principle of random and control, to divide the60patientscomplying with the standard of this research into two groups:30people in experimentalgroup and30in control group. Treat the experimental group with Chinese medicines on thebasis of conventional therapy with western medicine, using intravenous drip once a day.Meanwhile, treat the control group with western medicine only in conventional therapy. Toobserve the clinical general therapeutic effect, SIRS score, the syndrome effects, thehematology index before and after the cure and the untoward effects of all patients.Results: In the equal period of cure, experimental group’s SIRS score and syndromeeffects (p<0.05) and hematology index (p<0.01) are all better than control group.Conclusion: drugs for promoting blood circulation and removing stasis should beapplied into the patients of SIRS, which can noticeably improve patients’ clinical efficacyand control the reaction degree of inflammation. To combine western medicines withChinese medicines together into disease cure can promote clinical effectiveness. Themechanism of the above phenomenon may lie in the remarkable healing efficacy of drug for promoting blood circulation and removing stasis on enhancing immunity, resistingoxidation, clearing inflammatory factor, protecting vascular endothelial cells, improvingthe microcirculation and and supplying oxygen and so on.